Biotechnology News

July 3, 2012

BONN, Germany--(BUSINESS WIRE)--Cardionovum® begins in vivo testing of its paclitaxel-coated RESTORE® drug-eluting balloon

July 3, 2012

SEATTLE--(BUSINESS WIRE)--July 3, 2012–-Dendreon Corporation (NASDAQ: DNDN) today announced that John H. Johnson, president and chief executive officer, has assumed the additional title of Chairman of the Board, as of July 1, 2012. Mr. Johnson...

July 3, 2012

BEDMINSTER, N.J.--(BUSINESS WIRE)--NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) will present at the Seventh Annual JMP Securities Healthcare Conference in New York on Thursday, July 12, 2012 at 1:30 p.m. ET. The presentation will be available as a...

July 3, 2012

FLAGSTAFF, Ariz.--(BUSINESS WIRE)--Gore Hybrid Vascular Graft Wins Gold in the 2012 Medical Design Excellence Awards

July 3, 2012

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, announced today that Ms. Anu Sharma has joined the Company as Senior...

July 3, 2012

SAN DIEGO--(BUSINESS WIRE)--Santarus to present at seventh annual JMP Securities Healthcare Conference

July 3, 2012

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology and hematology, today announced the initiation...

July 3, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today announced the inaugural Langer Summit on Neurotrauma being held in...

July 3, 2012

SAINT-PREX, Switzerland & GOTHENBURG, Sweden--(BUSINESS WIRE)--Ferring acquires licensing rights for Elobixibat, a first-in-class compound for chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C); from...

July 3, 2012

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: September 2011 – May 2012 Quarterly Report Diamyd Medical AB (publ), fiscal year 2011/2012 (www.omxgroup.com ticker: DIAM B;...

July 3, 2012

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Diamyd Medical AB (STO:DIAMB) (Pink Sheets: DMYDY) reports that a Phase II study evaluating the Company’s drug candidate NP2 Enkephalin did not meet its primary objective of reducing pain in subjects...

July 3, 2012

PARIS--(BUSINESS WIRE)--Nomination de nouveaux membres au sein du
Conseil d’Administration de Theradiag

July 2, 2012

NEW YORK--(BUSINESS WIRE)--Forest Laboratories, Inc. (NYSE: FRX) today issued the following statement in response to a letter it received from Carl C. Icahn: “We are not surprised by Mr. Icahn’s theatrical display of self-serving rhetoric, but...

July 2, 2012

THE WOODLANDS, Texas--(BUSINESS WIRE)--Pernix Therapeutics Holdings, Inc. (“Pernix” or the “Company”) (NYSE MKT: PTX), a specialty pharmaceutical company, today announced that it has entered into a definitive agreement to acquire Great Southern...

July 2, 2012

BRIDGEWATER, N.J.--(BUSINESS WIRE)--CorMedix Inc. (“CorMedix”) (NYSE Amex: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of Cardiorenal disease, announces the...

July 2, 2012

ARLINGTON, Tenn.--(BUSINESS WIRE)--Wright Medical Group, Inc. (NASDAQ: WMGI), a global orthopaedic medical device company, today announced the full commercial launch of the ORTHOLOC™ 3Di Reconstruction Plating System for foot and ankle surgery....

July 2, 2012

SAN FRANCISCO & PARIS--(BUSINESS WIRE)--SpineGuard reports 20,000 spine procedures performed using its family of PediGuard® devices for accurate pedicle screw placement

July 2, 2012

NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb to Announce Results for Second Quarter 2012 on July 25

July 2, 2012

WASHINGTON--(BUSINESS WIRE)--BIO applauds the Navy, USDA, DOE announcements to support ongoing R&D and development of a demonstration advanced biofuel integrated biorefinery for military biofuel.

July 2, 2012

PARIS--(BUSINESS WIRE)--Regulatory News: BioAlliance Pharma SA (Euronext Paris - BIO), an innovation Company dedicated to the development of orphan oncology products and specialty products, has announced today the completion of phase I clinical...

July 2, 2012

ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. today announced that two patients at two different hospitals were treated with its new, 6 French guide catheter-compatible, electric orbital atherectomy system.

July 2, 2012

SALT LAKE CITY--(BUSINESS WIRE)--Great Basin Corporation, a privately-held molecular diagnostics company developing sample-to-result solutions, announced today that a study published in the July issue of the Journal of Clinical Microbiology...

July 2, 2012

LOS ANGELES--(BUSINESS WIRE)--ImmunoCellular Therapeutics, Ltd. (“ImmunoCellular” or the “Company”) (NYSE MKT: IMUC), a clinical stage biotechnology company that is focused on developing new immune-based products to treat cancer, announced today...

July 2, 2012

MISGAV, Israel & SAN FRANCISCO--(BUSINESS WIRE)--Medgenics, Inc. (NYSE MKT: MDGN and AIM: MEDU, MEDG), the developer of BiopumpTM, a novel technology for the sustained production and delivery of therapeutic proteins in patients using their...

July 2, 2012

BIRMINGHAM, Ala.--(BUSINESS WIRE)--SBIR award will focus on high-throughput screening and discovery of new drugs that stimulate endogenous secretion of adiponectin as a therapeutic for metabolic disease.

July 2, 2012

BURLINGTON, N.C.--(BUSINESS WIRE)--Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) announced today that its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) may be converted as set forth below. The Zero...

July 2, 2012

NO. BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Medical Imaging, Inc., a global leader in developing, manufacturing and distributing innovative diagnostic imaging agents, today announced the publication of the results from the CaRES multicenter...

July 2, 2012

LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (NASDAQ:CYTR), a biopharmaceutical company specializing in oncology, today announced that the European Patent Office (EPO) has issued a patent covering the Company’s tumor-targeting linker platform...

July 2, 2012

BEDMINSTER, N.J.--(BUSINESS WIRE)--NPS Pharmaceuticals, Inc. (NASDAQ: NPSP), a specialty pharmaceutical company developing orphan therapeutics for rare gastrointestinal and endocrine disorders, today announced that it has amended its license...

July 2, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that Robert J. Perez, currently Executive Vice President and Chief Operating Officer (COO), has been named President and COO, and Michael Tomsicek,...

July 2, 2012

COLUMBIA, Md.--(BUSINESS WIRE)--Osiris Therapeutics, Inc. (NASDAQ: OSIR), announced today interim one-year results from its groundbreaking clinical trial evaluating Prochymal® (remestemcel-L) for the treatment of patients experiencing first-time...

July 2, 2012

SAN ANTONIO--(BUSINESS WIRE)--Mike Mathews Named Senior Vice President, International at KCI; Mathews to Lead Commercial Business Activities in International Markets

July 2, 2012

ROCKVILLE, Md.--(BUSINESS WIRE)--Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it has submitted an...

July 2, 2012

NEW YORK--(BUSINESS WIRE)--Forest Laboratories, Inc. (NYSE: FRX), an international manufacturer and marketer of pharmaceutical products, will release its Fiscal 2013 First Quarter financial results before the U.S. stock market opens on Tuesday,...

July 2, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--Interleukin Genetics completes $3,000,000 private placement with its strategic partner Delta Dental Plan of Michigan to advance genetic testing services

July 2, 2012

MENLO PARK, Calif.--(BUSINESS WIRE)--Two papers in Nature Biotechnology, both published online on July 1, 2012 highlight the unique value for de novo genome assembly provided by the PacBio® RS High Resolution Genetic Analyzer.

July 2, 2012

TEL AVIV, Israel--(BUSINESS WIRE)--Compugen announced the development of "NexGen," a new platform designed to significantly enhance Compugen’s overall infrastructure for predictive drug and drug target discovery.

July 2, 2012

SAN CARLOS, Calif.--(BUSINESS WIRE)--Natus Medical Incorporated (Nasdaq:BABY) today announced that it has completed the acquisition of the Nicolet neurodiagnostic business from CareFusion (NYSE: CFN) that was announced on April 23, 2012. Based in...

July 2, 2012

LIMERICK, Pa.--(BUSINESS WIRE)--Teleflex Receives FDA 510(k) Clearance for CVP Monitoring Indication on the ArrowADVANTAGE Pressure-Injectable PICC

July 2, 2012

EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (NASDAQ: ATRS) today announced the appointment of Jonathan S. Jaffe MD to the position of Vice President of Clinical Development. Jonathan’s background includes a 12 year post-graduate career in...

July 2, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI) and other neurological injuries, today announced a novel hydrogel based...

July 2, 2012

COLD SPRING HARBOR, N.Y.--(BUSINESS WIRE)--The next “next-gen” technology in genome sequencing has gotten a major boost. Researchers at CSHL have fixed a serious problem in the newest genome sequencing technology: an error rate as high as 20%